JS

Jann Skinner

Telix Pharmaceuticals Limited | Non-Executive Director
Ms Skinner was a partner at PricewaterhouseCoopers from 1987 to 2004. She has served as Chair of Create Foundation Limited since July 2024 and Director since 2004. She also served as Non-Executive Director of QBE Insurance Group Limited from October 2014 to May 2024 and Director of HSBC Bank Australia Limited from April 2017 to April 2023. She is Chair of Risk Committee and member of people committee.

Company and Role

Company
Title
Tenure
Since
TLX
TLX
Telix Pharmaceuticals Limited
  • Non-Executive Director
8yrsJun 2018

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TLX
TLX
Telix Pharmaceuticals Limited
30/12/25N/A595,000N/AN/A
QBE
QBE
30/12/23N/A70,000N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
TLX
TLX
Telix Pharmaceuticals Limited
09/11/22
Exercise
495,000$1.090$539,550Exercise of options
TLX
TLX
Telix Pharmaceuticals Limited
09/11/22
Issued
495,000$1.090$539,550Exercise of options
QBE
QBE
08/03/21
Buy
6,005$9.500$57,047On-market trade
QBE
QBE
20/05/20
Issued
3,995$7.510$30,002Participation in share purchase plan
QBE
QBE
11/03/20
Buy
10,000$11.100$111,000On-market trade